While numerous studies have documented alterations in the expression of ER, PR, and apoptotic regulators like BCL-2 across different endometriosis tissues and menstrual phases [18,20], the findings are often inconsistent, reflecting variability in study designs, patient populations, and lesion types. The gene discussed is PGR; the disease is endometriosis.